Crescent Capital BDC (CCAP) EBIT (2021 - 2026)

Crescent Capital BDC (CCAP) has reported EBIT for 6 consecutive years, with -$22.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 11.62% year-over-year to -$22.7 million; the trailing twelve-month figure through Jun 2026 stood at -$92.6 million (up 10.99% YoY), and the FY2025 full-year result was -$98.7 million, up 7.57% from the prior year.
• EBIT retreated to -$22.7 million in Q2 2026 per CCAP's latest filing, from -$21.9 million in the prior quarter.
• Across five years, EBIT topped out at $16.1 million in Q4 2022 and bottomed at -$27.4 million in Q3 2024.
• Historically, EBIT has averaged -$17.6 million across 5 years, with a median of -$24.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: EBIT gained 28.98% in 2022, then tumbled 266.34% in 2023.
• Over 5 years, EBIT stood at $16.1 million in 2022, then sank by 266.34% to -$26.8 million in 2023, then advanced by 3.52% to -$25.8 million in 2024, then advanced by 7.78% to -$23.8 million in 2025, then advanced by 4.67% to -$22.7 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$22.7 million, -$21.9 million, and -$23.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.